# Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan

> **NCT00602147** · — · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 95 (actual)

## Conditions studied

- Mucositis
- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00602147
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2009-01
- **Final completion:** 2010-04
- **Target enrollment:** 95 (ACTUAL)
- **Why stopped:** The original PI on this study left VICC, thus study was closed.
- **Last updated:** 2013-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00602147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00602147, "Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00602147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*